Teachers Retirement System of The State of Kentucky boosted its stake in shares of Davita Inc (NYSE:DVA) by 2,754.0% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 266,850 shares of the company’s stock after acquiring an additional 257,500 shares during the quarter. Teachers Retirement System of The State of Kentucky’s holdings in Davita were worth $21,119,000 as of its most recent SEC filing.
Other institutional investors also recently added to or reduced their stakes in the company. Capital Analysts LLC acquired a new position in Davita during the second quarter worth $28,000. First Manhattan Co. increased its stake in shares of Davita by 178.5% in the first quarter. First Manhattan Co. now owns 401 shares of the company’s stock valued at $30,000 after buying an additional 257 shares in the last quarter. Berman Capital Advisors LLC increased its stake in shares of Davita by 265.4% in the second quarter. Berman Capital Advisors LLC now owns 570 shares of the company’s stock valued at $43,000 after buying an additional 414 shares in the last quarter. Rockefeller Capital Management L.P. increased its stake in shares of Davita by 257.7% in the first quarter. Rockefeller Capital Management L.P. now owns 651 shares of the company’s stock valued at $50,000 after buying an additional 469 shares in the last quarter. Finally, CSat Investment Advisory L.P. increased its stake in shares of Davita by 16.0% in the second quarter. CSat Investment Advisory L.P. now owns 1,063 shares of the company’s stock valued at $84,000 after buying an additional 147 shares in the last quarter. Hedge funds and other institutional investors own 91.56% of the company’s stock.
A number of analysts have recently weighed in on DVA shares. Raymond James restated a “hold” rating on shares of Davita in a research note on Tuesday. ValuEngine upgraded Davita from a “strong sell” rating to a “sell” rating in a research note on Tuesday, September 1st. SunTrust Banks lifted their price objective on Davita from $90.00 to $100.00 and gave the stock a “hold” rating in a research report on Friday, July 31st. Finally, Zacks Investment Research upgraded Davita from a “hold” rating to a “buy” rating and set a $100.00 price objective for the company in a research report on Monday, August 3rd. One analyst has rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $77.83.
NYSE DVA traded up $2.00 during trading on Wednesday, hitting $91.84. The stock had a trading volume of 1,129,619 shares, compared to its average volume of 1,294,252. The company has a market capitalization of $10.96 billion, a PE ratio of 14.49 and a beta of 1.20. The company’s 50-day moving average price is $86.16 and its two-hundred day moving average price is $80.17. The company has a debt-to-equity ratio of 3.38, a quick ratio of 1.33 and a current ratio of 1.35. Davita Inc has a 12 month low of $54.08 and a 12 month high of $92.67.
Davita (NYSE:DVA) last released its earnings results on Thursday, July 30th. The company reported $1.95 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.30 by $0.65. The firm had revenue of $2.88 billion for the quarter, compared to analysts’ expectations of $2.91 billion. Davita had a return on equity of 40.78% and a net margin of 7.20%. As a group, equities analysts anticipate that Davita Inc will post 6.75 earnings per share for the current fiscal year.
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Featured Story: Google Finance
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.